IMM2504

N/A

Report date: 2024/11/15 15:35:00

Base Information

Drug NameIMM2504
Drug Alias NameIMM-2504IMM2504
ClassificationBiologics
Mechanisms of ActionCluster of differentiation 47 inhibitorsProgrammed death-ligand 1 blockersVascular endothelial growth factor inhibitors
TargetsCluster of differentiation 47Programmed death-ligand 1Vascular endothelial growth factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A